Congo's health ministry says two of the first 10 people to receive an experimental treatment for the Ebola virus in the latest outbreak have recovered, and monitoring could show what role the treatment played.
The head of the World Health Organisation yesterday congratulated Congo's government for making several experimental treatments available in this Ebola outbreak, calling it "a global first, and a ray of hope for people with the disease".
The two people received the mAb114 treatment isolated from a survivor of an Ebola outbreak in 1995.
It was the first of five experimental treatments Congo approved for use in the outbreak that was declared on August 1.
Congo says 77 Ebola cases have been confirmed, including 39 deaths and 11 recoveries. There are another 28 probable cases in which biological samples are not available for laboratory testing.
Nearly 3,000 people, in this outbreak, have received an experimental Ebola vaccine.
Ebola, a haemorrhagic fever, is spread via contact with bodily fluids of those infected, including the dead. It can be fatal in up to 90 per cent of cases, depending on the strain.
This is Congo's 10th outbreak of the virus and the first in North Kivu province, which aside from the resident population, hosts an estimated one million people displaced by fighting.